Cargando…
A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. The number of cases of PD is expected to double by 2030, representing a heavy burden on the healthcare system. Clinical symptoms include the progressive loss of dopaminergic neurons in the substantia nigra of the midbrain...
Autores principales: | Salemi, Michele, Lanza, Giuseppe, Mogavero, Maria Paola, Cosentino, Filomena I. I., Borgione, Eugenia, Iorio, Roberta, Ventola, Giovanna Maria, Marchese, Giovanna, Salluzzo, Maria Grazia, Ravo, Maria, Ferri, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836138/ https://www.ncbi.nlm.nih.gov/pubmed/35163455 http://dx.doi.org/10.3390/ijms23031535 |
Ejemplares similares
-
Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
por: Salemi, Michele, et al.
Publicado: (2022) -
mRNA expression profiling of mitochondrial subunits in subjects with Parkinson’s disease
por: Salemi, Michele, et al.
Publicado: (2021) -
Long non-coding RNA GAS5 expression in patients with Down syndrome
por: Salemi, Michele, et al.
Publicado: (2020) -
Uncharacterized RNAs in Plasma of Alzheimer’s Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power
por: Barbagallo, Cristina, et al.
Publicado: (2020) -
Association study of COX-2 (PTGS2) –765 G/C promoter
polymorphism by pyrosequencing in Sicilian patients with Alzheimer's
disease
por: Salemi, Michele, et al.
Publicado: (2014)